Medical Treatment of Nasal Airway Obstruction
- PMID: 29914725
- DOI: 10.1016/j.otc.2018.05.004
Medical Treatment of Nasal Airway Obstruction
Abstract
Nasal obstruction is a common, and potentially debilitating, problem. It is caused by a combination of structural factors and/or mucosal swelling/inflammation. The medical treatment of nasal obstruction is aimed at decreasing mucosal inflammation and edema and is generally guided by the underlying cause. Several different drug classes are commonly used in the treatment of nasal obstruction, each with different indications, and pros and cons to their use. This article discusses the most commonly used therapies for nasal obstruction. Current evidence on the efficacy and side effect profile of each therapy is reviewed.
Keywords: Decongestant; Intranasal corticosteroid; Medication; Nasal obstruction; Pharmacotherapy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Rise and fall of decongestants in treating nasal congestion related diseases.Expert Opin Pharmacother. 2024 Oct;25(14):1943-1951. doi: 10.1080/14656566.2024.2411009. Epub 2024 Oct 6. Expert Opin Pharmacother. 2024. PMID: 39344778 Review.
-
Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments.Paediatr Drugs. 2008;10(3):151-62. doi: 10.2165/00148581-200810030-00004. Paediatr Drugs. 2008. PMID: 18454568 Review.
-
Brazilian Academy of Rhinology position paper on topical intranasal therapy.Braz J Otorhinolaryngol. 2013 May-Jun;79(3):391-400. doi: 10.5935/1808-8694.20130067. Braz J Otorhinolaryngol. 2013. PMID: 23743757 Free PMC article. Review.
-
Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.Rhinology. 2003 Sep;41(3):167-74. Rhinology. 2003. PMID: 14579657 Clinical Trial.
-
Acute coronary syndrome after nasal spray of oxymetazoline.Chest. 2014 Dec;146(6):e214-e215. doi: 10.1378/chest.14-1873. Chest. 2014. PMID: 25451367 No abstract available.
Cited by
-
The Prevalence of the Nasal Vestibular Body in Patients With Nasal Obstruction.Cureus. 2024 Mar 14;16(3):e56194. doi: 10.7759/cureus.56194. eCollection 2024 Mar. Cureus. 2024. PMID: 38618310 Free PMC article.
-
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features.Mol Cell Biochem. 2022 Mar;477(3):711-726. doi: 10.1007/s11010-021-04325-9. Epub 2022 Jan 11. Mol Cell Biochem. 2022. PMID: 35013850 Free PMC article. Review.
-
Topical Anesthesia Versus Submucosal Injection for Radiofrequency Turbinoplasty: Same Benefit but without Patient's Pain. A Comparative Study.Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):3831-3839. doi: 10.1007/s12070-024-04716-6. Epub 2024 May 20. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 39376329
-
Temperature-Controlled Radiofrequency Treatment of the Nasal Valve in Patients With Nasal Obstruction: Long-Term Outcomes.Otolaryngol Head Neck Surg. 2025 Apr;172(4):1214-1223. doi: 10.1002/ohn.1118. Epub 2025 Jan 17. Otolaryngol Head Neck Surg. 2025. PMID: 39822054 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous